CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

Acrizanib

Small moleculeexperimental

Clinical trial activity

2 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2014 (NCT02076919)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • lha510

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02355028Phase 2Mar 1, 2015Novartis
NCT02076919Phase 1Feb 1, 2014Alcon
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AlconFor profit1112014
NovartisFor profit1112015
2 organizations
Page 1 / 1